scholarly journals Da-Cheng-Qi Decoction Combined with Conventional Treatment for Treating Postsurgical Gastrointestinal Dysfunction

2017 ◽  
Vol 2017 ◽  
pp. 1-8 ◽  
Author(s):  
Wei Jin ◽  
Qingjie Li ◽  
Xiaoqiong Luo ◽  
Juan Zhong ◽  
Yang Song ◽  
...  

Aim. To assess the current clinical evidence of the effectiveness of Da-Cheng-Qi Decoction (DCQD) for the treatment of Postoperative gastrointestinal dysfunction (PGD).Methods. Randomized controlled trails (RCTs) of Da-Cheng-Qi Decoction (DCQD) to PGD were searched from available major electronic databases to September 2016. The intervention must be a modified DCQD or DCQD integrated to Western Medicine (WM) compared with WM or placebo or blank. The main outcome index was clinical effectiveness and improvement of major symptoms. Data extraction, data analysis, and methodological quality assessment are conducted according to the Cochrane Handbook for Systematic Review of Interventions, version 5.0.2. RevMan 5.3 software was applied to our data analyses.Results. Seven RCTs involving 494 participants were recruited and identified. The methodological quality of all trials were assessed and generally of low-level. Those studies were published between 2004 and 2013. All 7 studies which used herbals (modified DCQD) integrate WM in test group compared with WM as the intervention and only one study (Sunyouxu 2013) integrates placebo to Western Medicine as the control group intervention. The treatment course was 1 week to 2 weeks. Evaluation of intervention effectiveness consists of the clinical effective rate indicator and the PGD symptoms indicator including time of borborygmus, time of gastrointestinal exhaust, and time of defecate. The clinical effectiveness results are beneficial to the test group.Conclusion. DCQD could improve PGD symptoms and promotion clinical effectiveness.

2018 ◽  
Vol 36 (5) ◽  
pp. 295-301 ◽  
Author(s):  
Shanshan Li ◽  
Weiqiang Zhong ◽  
Wen Peng ◽  
Gaofeng Jiang

Objective To assess the clinical effectiveness of acupuncture in the treatment of postpartum depression (PPD). Methods The following electronic databases were systematically searched: PubMed, Cochrane Library, SCI, Elsevier SDOL, China National Knowledge, Wan Fang database and Chinese Science and Technology Periodical Database. Only randomised controlled trials (RCTs) of acupuncture for PPD were considered. Primary outcomes were the Hamilton Rating Scale for Depression (HAMD) or the Edinburgh Postnatal Depression Scale (EPDS) scores and effective rate. Our secondary outcome was the level of oestradiol. The quality of all included trials was evaluated according to the Cochrane Collaboration. This protocol was registered in PROSPERO (CRD42016048528). Results Nine trials involving 653 women were selected. The result of this meta-analysis demonstrated that the acupuncture group had a significantly greater overall effective rate compared with the control group (seven trials, n=576, I2=24%; relative risk (RR) 1.15, 95% CI 1.06 to 1.24; P<0.001). Moreover, acupuncture significantly increased oestradiol levels compared with the control group (mean difference (MD) 36.92, 95% CI 23.14 to 50.71, P<0.001). Regarding the HAMD and EPDS scores, no difference was found between the two groups (five trials, n=276, I2=82%; MD−1.38, 95% CI −3.40 to 0.64; P=0.18; two trials, n=60, I2=16%; MD 1.08, 95% CI −1.09 to 3.26; P=0.33). Conclusions Acupuncture appears to be effective for postpartum depression with respect to certain outcomes. However, the evidence thus far is inconclusive. Further high-quality RCTs following standardised guidelines with a low risk of bias are needed to confirm the effectiveness of acupuncture for postpartum depression.


2019 ◽  
Vol 39 (4) ◽  
Author(s):  
Chunqiu Liu ◽  
Yin Li ◽  
Xinqiu Wang ◽  
Tong Lu ◽  
Xuejing Wang

Abstract We performed a meta-analysis to evaluate the efficacy and safety of Western medicine combined with Tanreqing for patients with chronic obstructive pulmonary disease (COPD) and respiratory failure. We comprehensively searched several online databases from the times of their inception to November 2018. The trial quality was assessed using the bias risk tool recommended by the Cochrane library. Relative risks (RRs) and their 95% confidence intervals (CIs) for binary outcomes and weighted mean differences (MDs) with 95% CIs for continuous data were calculated. A fixed effect model indicated that integrated Tanreqing group experienced higher overall treatment effectiveness (RR = 1.23, 95% CI: 1.17–1.30, P=0.000). Pooled results from random effects models indicated the oxygen partial pressure of the test group was significantly higher than that of the control groups (MD = 9.55, 95% CI: 4.57–14.52, P<0.000). The carbon dioxide pressure of the test group was significantly lower than that of the control groups (MD = –6.06, 95% CI: –8.19 to –3.93, P=0.000). The lung function score of the test group was significantly higher than that of the control group (MD = 7.87, 95% CI: 4.45–11.29). Sensitivity analysis indicated that the data were statistically robust. Clinical effects of Western medicine combined with Tanreqing used to treat combined COPD/respiratory failure were better than those afforded by Western medicine; no serious adverse reactions were noted. However, publication bias was evident, and further trials with larger sample sizes are required.


2020 ◽  
Vol 48 (8) ◽  
pp. 030006052091957
Author(s):  
Fen-Qiao Chen ◽  
Wen-Zhong Xu ◽  
Hai-Yun Gao ◽  
Li-Juan Wu ◽  
He Zhang ◽  
...  

Objective To investigate Changweishu’s clinical effect on gastrointestinal dysfunction in patients with sepsis. Methods Fifty patients with gastrointestinal dysfunction and sepsis were randomly divided into treatment and control groups. The control group patients received routine Western medicine treatments (meropenem, noradrenaline, glutamine glue, Bifidobacterium lactis triple-strain tablet), and the treatment group patients received routine Western medicine treatment combined with Changweishu. Treatments in both groups lasted 7 days. Changes in APACHE II score, gastrointestinal dysfunction score, serum levels of diamine oxidase (DAO), D-lactic acid, inflammatory factors (tumor necrosis factor (TNF)-α, interleukin (IL)-6, and high-mobility group box 1 (HMGB-1)), and the incidence of multiple organ dysfunction syndrome (MODS) and mortality were observed. Results After treatment, APACHE II score, gastrointestinal dysfunction score, and DAO, D-lactic acid, TNF-α, IL-6, and HMGB-1 levels decreased significantly in both groups, but the decrease was more significant in the treatment group than in the control group. The incidence of MODS and mortality were significantly lower in the treatment group than in the control group. Conclusion The addition of Changweishu to routine Western treatments can improve gastrointestinal function in patients with sepsis and gastrointestinal dysfunction, as well as decreasing the incidence of MODS and mortality and improving patient prognosis.


2013 ◽  
Vol 2013 ◽  
pp. 1-11 ◽  
Author(s):  
Jiaxing Tian ◽  
Min Li ◽  
Jiangquan Liao ◽  
Junling Li ◽  
Xiaolin Tong

Objective. To assess the current clinical evidence of Banxiaxiexin decoction for diabetic gastroparesis (DGP).Methods. Electronic databases were searched until December 2012. No language limitations were applied. We included RCTs using Banxiaxiexin decoction/modified Banxiaxiexin decoction for DGP. No restriction for the control group except acupuncture. Applying clinical effective rate as the main outcome index. Data extraction, analyses and quality assessment were conducted according to the Cochrane review standards.Results. 16 RCTs involving 1302 patients were finally identified, and the methodological quality was evaluated as generally low. The data showed that the effect of Banxiaxiexin decoction (BXXD) for DGP was superior to the control group (n=1302, RR 1.23, 95% CI 1.17 to 1.29,Z=8.04,P<0.00001). Only one trial recorded adverse events, no obvious adverse event occurred.Conclusions. Banxiaxiexin decoction could regain the gastric emptying rate and improve diabetic gastrointestinal symptoms. However, the methodological quality of included studies is low, and long term efficacy and safety are still uncertain, which indicates that the findings above should be read with caution. Thereby, well-designed, large-scale, and high-quality randomized controlled clinical trials with scientific rigor are warranted for stronger evidence in future research.


2020 ◽  
Vol 8 (2) ◽  
Author(s):  
Liang Wen

Objective: To explore the clinical effect of the treatment of knee osteoarthritis with traditional Chinese medicine.Methods: 152 patients with knee osteoarthritis who were treated in our hospital from July 2018 to April 2020 were divided into two groups. Group A (control group) was treated with conventional western medicine, i.e. celecoxib 200 mg capsule +Glucosamine hydrochloride capsule 0.75g, group B (observation group): the treatment of traditional Chinese medicine sloughing using our experience formula, and further comparative evaluation of the treatment effect of the two groups. Results: the effective rate was 75% in the control group and 92% in the observation group. Conclusion: in the treatment of knee osteoarthritis, traditional Chinese medicine is more effective than western medicine.


2013 ◽  
Vol 2013 ◽  
pp. 1-11 ◽  
Author(s):  
Jie Wang ◽  
Bo Feng ◽  
Xingjiang Xiong

Objectives. To assess the clinical evidence of Chinese herbal medicine (CHM) for obesity-related hypertension. Search Strategy. Electronic databases were searched until January, 2013.Inclusion Criteria. We included randomized clinical trials (RCTs) testing CHM against nondrug therapy and conventional western medicine, or combined with conventional western medicine against conventional western medicine.Data Extraction and Analyses. Study selection, data extraction, quality assessment, and data analyses were conducted according to Cochrane standards.Results. 11 trials were included. Methodological quality was evaluated as low. 1 trial investigated the efficacy of CHM plus nondrug therapy versus nondrug therapy. Positive results in diastolic blood pressure (DBP) (WMD: −5.40 [-5.88,-4.92];P<0.00001) were found in combination group. 1 trial investigated the efficacy of CHM versus conventional western medicine. Positive results in systolic blood pressure (SBP) (WMD: −1.39 [-2.11,-0.67];P=0.0002) were found in CHM. 9 trials investigated the efficacy of CHM plus conventional western medicine versus conventional western medicine. Positive results in SBP (WMD: -6.71 [-11.08,-1.25];P=0.02) were found in combination group. The safety of CHM is unknown.Conclusions. No definite conclusion could be got due to poor methodological quality. Rigorously designed trials are warranted to confirm these results.


2021 ◽  
Vol 38 (2) ◽  
pp. 96-109
Author(s):  
Seung Min Lee ◽  
Cham Kyul Lee ◽  
Kyung Ho Kim ◽  
Eun Jung Kim ◽  
Chan Yung Jung ◽  
...  

The purpose of this study was to evaluate the effectiveness and safety of acupotomy for the treatment of patients with knee osteoarthritis. There were 9 databases searched to retrieve randomized controlled trials until August 3, 2019 regarding acupotomy versus conventional Western medicine, conventional Western medicine treatment with and without acupotomy, and Korean medicine treatment with and without acupotomy, and meta-analysis was performed. Of 303 potentially relevant studies retrieved, 43 were systematically reviewed. All studies were conducted in China. Effective rate, visual analogue scale, and Western Ontario and McMaster Universities Osteoarthritis index were used as the evaluation scales. The Ashi point was selected most frequently. In all studies, the intervention group was more effective than the control group. Meta-analysis revealed that acupotomy showed statistically significant beneficial results. Although acupotomy had a beneficial effect on knee osteoarthritis, the risk of bias of the included studies was not low. The majority of the results from the evaluation scales used were highly heterogeneous (> 50%) which reduced confidence in the estimation of effect, or had a small sample size. Further clinical research and development is required in the future.


2018 ◽  
Vol 2 (2) ◽  
Author(s):  
Yue Yan Huang

Objective To investigate antiviral and anti-inflammatory effects of medicated thread moxibustion combined with Shujin Jiannao granule in the treatment of HFMD. Methods A total of 124 children with HFMD were collected to divided into western medicine group (62 cases) and experimental group(62 cases) while 62 healthy children were enrolled to become normal control group. Western medicine group was treated according to conventional therapy while experimental group was treated with combined treatment of traditional Chinese medicine(TCM) and western medicine. To determine serum levels of S100B, NSE, CRP and WBC and observe the clinical effectiveness. Results In the western medicine group the total effectiveness rate is 88.7% while it is 96.8% in the experimental group(P<0.05); the average disappearance time of symptoms are shorter in the experimental group than that in the western medicine group(P<0.05). Compared with the control group,the serum levels of S100B, NSE, CRP and WBC all rise in HFMD children(P<0.05 or P<0.01). After treatment , the serum levels of S100B, NSE, CRP and WBC reduce in both the experimental group and the western medicine group, when compared with that before treatment.The difference is statistically significant(P<0.05 or P<0.01). 


2020 ◽  
Vol 7 (1) ◽  
pp. 19
Author(s):  
Sun Yan ◽  
Ling Feng ◽  
Xin Xiang-yang

Objective: To explore the effects of integrated traditional Chinese and western Medicine on the vision recovery and serum trace elements in patients with herpes simplex keratitis.Methods: A total of 86 cases of HSK patients admitted in Baogang Hospital of Inner Mongolia from January 2015 to October 2016 were selected and divided randomly into the observation group (n = 43) and the control group (n = 43) according to the random number table. The control group was treated with ganciclovir eye drops and chondroitin sulfate eye drops, and the observation group was treated with Qinggan Mingmu Decoction on the basis of the control group. The 2 groups were treated for 4 weeks continuously. The clinical efficacy was compared between two groups. The vision recovery, serum trace elements and tear immune factor levels were also compared between two groups before and after treatment.Results: After treatment, the effective rate of treatment in the observation group was significantly higher than that in the control group (p < .05); in the observation group of patients, visual analogue scale (VAS) score and visual acuity after treatment were obviously higher than those before treatment, and also remarkably higher than those in the control group of patients (p < .05); after treatment, the levels of Fe, Ca and Cu ions in the observation group were significantly lower than those in the control group and before treatment (p < .05); after treatment, the level of zinc ions in the serum in the observation group was significantly higher than that before treatment and in the control group (p < .05); after treatment, the levels of tear IgA, IgG and C3 in the observation group were prominently higher than those before treatment and in the control group (p < .05).Conclusions: In the treatment of HSK, integrated traditional Chinese and western medicine can promote effectively the vision recovery, regulate the level of trace elements in the serum and enhance the level of tear immune factors, with the clinical efficacy better than the treatment of western medicine alone.


2019 ◽  
Vol 24 (3) ◽  
pp. 233-235
Author(s):  
C. R. Ahmedbeyli

Relevance: to evaluate the clinical effectiveness of probiotic as an adjunct to professionally administered plaque removal (PAPR) in the treatment of peri-implant mucositis.Materials and methods: 42 patients with at least 2 implants with peri-implant mucositis and probing depth (PD) of 3-4 mm were selected and randomly divided into two groups. Test group received PAPR plus probiotic powder (Enteflavin® 4 g), whereas control group received PAPR only. Plaque index (PI), Gingival Index (GI), Bleeding on Probing (BoP), PD were measured at baseline and at days 21, 90, 180 and 360 after treatment.Results: TEST and control groups involved 21 patients with 61 implants and 21 patients with 59 implants, respectively. All clinical parameters were improved in both groups. Inter-group differences for PI, GI, BoP & PD were found to be statistically significant at all time periods after the treatment in favor of test group (p < 0.05).Conclusion: PAPR alone or in combination with probiotic powder revealed clinical improvements in peri-implant mucositis patients. Better results were obtained with the adjunctive administration of probiotic. Probiotic therapy may be useful for the prevention and treatment of peri-implant mucositis.


Sign in / Sign up

Export Citation Format

Share Document